Hexarelin

2mg

Lyophilized Powder

Hexarelin

Hexarelin is a potent growth hormone-releasing peptide (GHRP) known for its strong affinity in stimulating growth hormone release in laboratory studies. Each vial contains 2mg of lyophilized Hexarelin, ensuring high purity and stability, making it ideal for research purposes. The lyophilized powder format preserves its effectiveness and extends shelf life, offering researchers a reliable product for exploring growth hormone regulation, muscle recovery, and other physiological processes.

Research-supported actions commonly associated with Hexarelin:

• Stimulates Growth Hormone Release: Strongly promotes growth hormone secretion in lab settings.
• Supports Muscle Recovery: Commonly researched for its potential in muscle repair and recovery.
• Increases Strength: Known to aid in strength enhancement as observed in studies.
• Promotes Bone Density: Often explored for its effect on bone health and density.
• Potential Anti-Aging Properties: Investigated for impacts on age-related physiological functions.
• Cardioprotective Effects: Suggested in research to support heart health and cardiovascular function.
• Enhances Fat Loss: Known for its potential to influence fat metabolism in certain studies.
• Supports Tissue Repair: Frequently used in studies related to soft tissue and ligament health.

Features for Hexarelin:

• High-Purity Hexarelin: 2mg of premium-grade, lyophilized Hexarelin for accurate research outcomes.
• Lyophilized Powder: Freeze-dried to maximize stability and preserve product quality.
• Potent GHRP: Known for its strong binding and high affinity in growth hormone studies.
• Extended Shelf Life: Lyophilized for longevity and ease of storage in research environments.
• Easy-to-Use Format: Packaged in a secure vial for precise, convenient handling.
• Consistent Results: High purity and stability ensure reliable, repeatable study results.

Studies/Resources

• Growth hormone-releasing activity of hexarelin in humans: a dose-response study (Eur J Clin Pharmacol, 1994)
• Growth hormone status during long-term hexarelin therapy (J Clin Endocrinol Metab, 1998)
  

Safety Disclaimer

This product is intended for research purposes only. It is not intended for human consumption or medical use.